TY - JOUR
T1 - Baculovirus-induced fast-acting innate immunity kills liver-stage plasmodium
AU - Bin Emran, Talha
AU - Iyori, Mitsuhiro
AU - Ono, Yuki
AU - Amelia, Fitri
AU - Yusuf, Yenni
AU - Islam, Ashekul
AU - Alam, Asrar
AU - Tamura, Megumi
AU - Ogawa, Ryohei
AU - Matsuoka, Hiroyuki
AU - Yamamoto, Daisuke S.
AU - Yoshida, Shigeto
N1 - Publisher Copyright:
Copyright © 2018 by The American Association of Immunologists, Inc.
PY - 2018/10/15
Y1 - 2018/10/15
N2 - Baculovirus (BV), an enveloped insect virus with a circular dsDNA genome, possesses unique characteristics that induce strong innate immune responses in mammalian cells. In this study, we show that BV administration in BALB/c mice not only provides complete protection against a subsequent Plasmodium berghei sporozoite infection for up to 7 d after the injection but also eliminates existing liver-stage parasites completely. The elimination of sporozoites by BV was superior to that by primaquine, and this effect occurred in a TLR9-independent manner. At 6 h after BV administration, IFN-α and IFN-γ were robustly produced in the serum, and RNA transcripts of IFN-stimulated genes were markedly upregulated in the liver compared with control mice. The in vivo passive transfer of serum after BV administration effectively eliminated liver-stage parasites, and IFN-α neutralization abolished this effect, indicating that the BV liver-stage parasite-killing mechanism is downstream of the type I IFN signaling pathway. These findings provide evidence that BV-induced, fast-acting innate immunity completely kills liver-stage parasites and, thus, may lead to new malaria drug and vaccine strategies.
AB - Baculovirus (BV), an enveloped insect virus with a circular dsDNA genome, possesses unique characteristics that induce strong innate immune responses in mammalian cells. In this study, we show that BV administration in BALB/c mice not only provides complete protection against a subsequent Plasmodium berghei sporozoite infection for up to 7 d after the injection but also eliminates existing liver-stage parasites completely. The elimination of sporozoites by BV was superior to that by primaquine, and this effect occurred in a TLR9-independent manner. At 6 h after BV administration, IFN-α and IFN-γ were robustly produced in the serum, and RNA transcripts of IFN-stimulated genes were markedly upregulated in the liver compared with control mice. The in vivo passive transfer of serum after BV administration effectively eliminated liver-stage parasites, and IFN-α neutralization abolished this effect, indicating that the BV liver-stage parasite-killing mechanism is downstream of the type I IFN signaling pathway. These findings provide evidence that BV-induced, fast-acting innate immunity completely kills liver-stage parasites and, thus, may lead to new malaria drug and vaccine strategies.
UR - http://www.scopus.com/inward/record.url?scp=85054774330&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1800908
DO - 10.4049/jimmunol.1800908
M3 - 学術論文
C2 - 30209187
AN - SCOPUS:85054774330
SN - 0022-1767
VL - 201
SP - 2441
EP - 2451
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -